|
News For GSK From The Last 14 Days Check below for free stories on GSK the last two weeks. |
|
|
| June 12, 2013 |
| 19:54 EDT |  | GSK | GlaxoSmithKline investigates bribe claims in China, WSJ says
 Subscribe for More Information |
|
| 07:16 EDT | | GSK | GlaxoSmithKline fires head of R&D in China, WSJ says
GlaxoSmithKline has fired it's head of R&D in China after finding that he had incorporated "misinterpreted" data in a paper he helped write for a journal, Nature Medicine, according to The Wall Street Journal, citing the company. Reference Link |
|
| June 6, 2013 |
| 15:59 EDT | | GSK | FDA votes for modified restrictions on GSK's Avandia, Reuters says
Subscribe for More Information |
|
| 15:42 EDT |  | GSK | FDA panel revote reaffirms modified restrictions for GSK's Avandia, Reuters says
|
|
| 15:26 EDT | | GSK | FDA advisers say Glaxo Avandia vote may have been inaccurate, Bloomberg says
Advisers plan to take a break to assess problem with vote tally and plan to re-vote on GSK's Avandia after break, Bloomberg says. |
|
| 15:20 EDT | | GSK | FDA panel votes to modify market restrictions for Avandia, Reuters says
Subscribe for More Information |
|
| June 5, 2013 |
| 07:45 EDT |  | GSK | FDA to host a joint committee meeting
Joint Meeting of the Endocrinilogic & Metabolic Drugs Advisory Committee and the Drug Safety & Risk Management Advisory Committee where the discussion on both days will be on GlaxoSmithKline's New Drug Application (NDA) 21071 for AVANDIA (Rosiglitazone Maleate) tablets is being held in FDA Offices in Silver Spring, Maryland on June 5-6 beginning at 8 am. Webcast Link |
|
| June 4, 2013 |
| 07:06 EDT | | GSK | Response Genetics achieves milestone payments totaling $1M from GlaxoSmithKline
Subscribe for More Information |
|
|
|
|
|
